Sanofi (EPA:SAN)
France flag France · Delayed Price · Currency is EUR
75.52
-0.91 (-1.19%)
Aug 14, 2026, 5:39 PM CET

Sanofi Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
45,84343,62641,08137,81737,65137,761
Other Revenue
3,0763,0903,2053,2922,6531,414
48,91946,71644,28641,10940,30439,175
Revenue Growth
6.96%5.49%7.73%2.00%2.88%4.83%
Cost of Revenue
12,98712,92313,19512,61911,86912,251
Gross Profit
35,93233,79331,09128,49028,43526,924
Selling, General & Admin
9,8929,6169,2479,0038,7859,599
Research & Development
8,1057,8427,3946,5076,5015,692
Amortization of Goodwill & Intangibles
2,0861,7761,7491,9111,5781,580
Other Operating Expenses
5,4994,9093,8322,9481,1901,488
Operating Expenses
25,58224,14322,22220,36918,05418,359
Operating Income
10,3509,6508,8698,12110,3818,565
Interest Expense
-606-531-641-589-402-362
Interest & Investment Income
2863204135272393
Earnings From Equity Investments
-238-15560-1365539
Currency Exchange Gain (Loss)
-226-2-32
Other Non Operating Income (Expenses)
74122-268-574-1470
EBT Excluding Unusual Items
9,8649,4088,4397,34710,2568,317
Merger & Restructuring Charges
-1,607-1,264-1,406-1,039-1,090-824
Gain (Loss) on Sale of Investments
-9-9--113
Gain (Loss) on Sale of Assets
382485539484481418
Asset Writedown
-3,062-2,241-248-896203-192
Legal Settlements
-293-255-470-196-143-
Other Unusual Items
-80-104-96416284115
Pretax Income
5,1956,0206,7586,1159,9927,837
Income Tax Expense
1,2031,0431,2041,0171,9091,558
Earnings From Continuing Operations
3,9924,9775,5545,0988,0836,279
Earnings From Discontinued Operations
192,87464338401-
Net Income to Company
4,0117,8515,6185,4368,4846,279
Minority Interest in Earnings
-53-38-58-36-113-56
Net Income
3,9587,8135,5605,4008,3716,223
Net Income to Common
3,9587,8135,5605,4008,3716,223
Net Income Growth
-56.63%40.52%2.96%-35.49%34.52%-49.38%
Shares Outstanding (Basic)
1,2081,2201,2511,2521,2521,253
Shares Outstanding (Diluted)
1,2131,2261,2561,2561,2571,258
Shares Change
-2.54%-2.43%-0.02%-0.04%-0.08%-0.18%
EPS (Basic)
3.286.404.444.316.694.97
EPS (Diluted)
3.266.374.444.316.674.95
EPS Growth
-55.56%43.55%2.94%-35.31%34.73%-49.28%
Free Cash Flow
10,0398,9887,3488,6398,9979,044
Free Cash Flow Per Share
8.287.335.856.887.167.19
Dividend Per Share
4.1204.1203.9203.7603.5603.330
Dividend Growth
5.10%5.10%4.25%5.62%6.91%4.06%
Gross Margin
73.45%72.34%70.20%69.30%70.55%68.73%
Operating Margin
21.16%20.66%20.03%19.75%25.76%21.86%
Profit Margin
8.09%16.72%12.55%13.14%20.77%15.88%
Free Cash Flow Margin
20.52%19.24%16.59%21.02%22.32%23.09%
EBITDA
13,54312,63811,66511,07613,09311,251
EBITDA Margin
27.68%27.05%26.34%26.94%32.49%28.72%
D&A For EBITDA
3,1932,9882,7962,9552,7122,686
EBIT
10,3509,6508,8698,12110,3818,565
EBIT Margin
21.16%20.66%20.03%19.75%25.76%21.86%
Effective Tax Rate
23.16%17.33%17.82%16.63%19.11%19.88%